These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 23902407)
21. Persistence of Lactobacillus reuteri DSM17938 in the human intestinal tract: response to consecutive and alternate-day supplementation. Smith TJ; Anderson D; Margolis LM; Sikes A; Young AJ J Am Coll Nutr; 2011 Aug; 30(4):259-64. PubMed ID: 21917706 [TBL] [Abstract][Full Text] [Related]
22. Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: a double-blind, randomized, placebo-controlled trial. Kim JY; Kwon JH; Ahn SH; Lee SI; Han YS; Choi YO; Lee SY; Ahn KM; Ji GE Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 2):e386-93. PubMed ID: 19840300 [TBL] [Abstract][Full Text] [Related]
23. Perinatal probiotic intervention prevented allergic disease in a Caesarean-delivered subgroup at 13-year follow-up. Kallio S; Kukkonen AK; Savilahti E; Kuitunen M Clin Exp Allergy; 2019 Apr; 49(4):506-515. PubMed ID: 30472801 [TBL] [Abstract][Full Text] [Related]
24. Long-term safety and efficacy of perinatal probiotic intervention: Evidence from a follow-up study of four randomized, double-blind, placebo-controlled trials. Lundelin K; Poussa T; Salminen S; Isolauri E Pediatr Allergy Immunol; 2017 Mar; 28(2):170-175. PubMed ID: 27779809 [TBL] [Abstract][Full Text] [Related]
25. Postnatal probiotics and allergic disease in very preterm infants: Sub-study to the ProPrems randomized trial. Plummer EL; Chebar Lozinsky A; Tobin JM; Uebergang JB; Axelrad C; Garland SM; Jacobs SE; Tang MLK; Allergy; 2020 Jan; 75(1):127-136. PubMed ID: 31608448 [TBL] [Abstract][Full Text] [Related]
27. Regulatory T cells and Toll-like receptor 2 and 4 mRNA expression in infants with colic treated with Savino F; Galliano I; Garro M; Savino A; Daprà V; Montanari P; Bergallo M Benef Microbes; 2018 Dec; 9(6):917-925. PubMed ID: 30406696 [TBL] [Abstract][Full Text] [Related]
28. Effects of Lactobacillus rhamnosus HN001 in early life on the cumulative prevalence of allergic disease to 11 years. Wickens K; Barthow C; Mitchell EA; Kang J; van Zyl N; Purdie G; Stanley T; Fitzharris P; Murphy R; Crane J Pediatr Allergy Immunol; 2018 Dec; 29(8):808-814. PubMed ID: 30430649 [TBL] [Abstract][Full Text] [Related]
29. Prenatal and postnatal probiotics reduces maternal but not childhood allergic diseases: a randomized, double-blind, placebo-controlled trial. Ou CY; Kuo HC; Wang L; Hsu TY; Chuang H; Liu CA; Chang JC; Yu HR; Yang KD Clin Exp Allergy; 2012 Sep; 42(9):1386-96. PubMed ID: 22925325 [TBL] [Abstract][Full Text] [Related]
30. Lactobacillus reuteri-induced regulatory T cells protect against an allergic airway response in mice. Karimi K; Inman MD; Bienenstock J; Forsythe P Am J Respir Crit Care Med; 2009 Feb; 179(3):186-93. PubMed ID: 19029003 [TBL] [Abstract][Full Text] [Related]
31. A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. Wickens K; Black PN; Stanley TV; Mitchell E; Fitzharris P; Tannock GW; Purdie G; Crane J; J Allergy Clin Immunol; 2008 Oct; 122(4):788-794. PubMed ID: 18762327 [TBL] [Abstract][Full Text] [Related]
33. Effectiveness of Lactobacillus reuteri DSM 17938 for the Prevention of Nosocomial Diarrhea in Children: A Randomized, Double-blind, Placebo-controlled Trial. Urbańska M; Gieruszczak-Białek D; Szymański H; Szajewska H Pediatr Infect Dis J; 2016 Feb; 35(2):142-5. PubMed ID: 26551445 [TBL] [Abstract][Full Text] [Related]
34. Lactobacillus reuteri supplements do not affect salivary IgA or cytokine levels in healthy subjects: A randomized, double-blind, placebo-controlled, cross-over trial. Jørgensen MR; Keller MK; Kragelund C; Hamberg K; Ericson D; Nielsen CH; Twetman S Acta Odontol Scand; 2016 Jul; 74(5):399-404. PubMed ID: 27104984 [TBL] [Abstract][Full Text] [Related]
35. Lactobacillus reuteri DSM 17938 in the prevention of antibiotic-associated diarrhoea in children: a randomized clinical trial. Kołodziej M; Szajewska H Clin Microbiol Infect; 2019 Jun; 25(6):699-704. PubMed ID: 30149135 [TBL] [Abstract][Full Text] [Related]
36. Pre- and postnatal Lactobacillus reuteri treatment alters DNA methylation of infant T helper cells. Forsberg A; Huoman J; Söderholm S; Bhai Mehta R; Nilsson L; Abrahamsson TR; Ernerudh J; Gustafsson M; Jenmalm MC Pediatr Allergy Immunol; 2020 Jul; 31(5):544-553. PubMed ID: 32150651 [TBL] [Abstract][Full Text] [Related]
37. Probiotics in pregnant women to prevent allergic disease: a randomized, double-blind trial. Dotterud CK; Storrø O; Johnsen R; Oien T Br J Dermatol; 2010 Sep; 163(3):616-23. PubMed ID: 20545688 [TBL] [Abstract][Full Text] [Related]
38. Prophylactic use of a probiotic in the prevention of colic, regurgitation, and functional constipation: a randomized clinical trial. Indrio F; Di Mauro A; Riezzo G; Civardi E; Intini C; Corvaglia L; Ballardini E; Bisceglia M; Cinquetti M; Brazzoduro E; Del Vecchio A; Tafuri S; Francavilla R JAMA Pediatr; 2014 Mar; 168(3):228-33. PubMed ID: 24424513 [TBL] [Abstract][Full Text] [Related]
39. The Efficacy and Safety of the Probiotic Bacterium Lactobacillus reuteri DSM 17938 for Infantile Colic: A Meta-Analysis of Randomized Controlled Trials. Xu M; Wang J; Wang N; Sun F; Wang L; Liu XH PLoS One; 2015; 10(10):e0141445. PubMed ID: 26509502 [TBL] [Abstract][Full Text] [Related]
40. Probiotics in infants for prevention of allergic disease and food hypersensitivity. Osborn DA; Sinn JK Cochrane Database Syst Rev; 2007 Oct; (4):CD006475. PubMed ID: 17943912 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]